Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Parkinsons

Berkeley Lab Scientists Help Develop Promising Therapy for Huntington’s Disease

There’s new hope in the fight against Huntington’s disease. A group of researchers that includes scientists from the U.S. Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab) have designed a compound that suppresses symptoms of the devastating disease in mice.

The compound is a synthetic antioxidant that targets mitochondria, an organelle within cells… Berkeley Lab Scientists Help Develop Promising Therapy for Huntington’s Disease   



Research uncovers a potential link between Parkinson’s and visual problems

The most common genetic cause of Parkinson’s is not only responsible for the condition’s distinctive movement problems but may also affect vision, according to new research by scientists at the University of York.

Parkinson’s, the second most common form of neurodegenerative disease, principally affects people aged over 60. Its most common symptom is tremor… Research uncovers a potential link between Parkinson’s and visual problems   



People with Parkinson’s strengthen their balance

Leading classes to help people with Parkinson’s disease to do better with their flexibility and balance is something Anthony Krumbholz does in part to honor his father.

Krumbholz, a 34-year-old Muscatine firefighter, leads Delay the Disease classes at the Muscatine Community Y twice each week. His father, John, who lives with Parkinson’s disease, is… People with Parkinson’s strengthen their balance   



Cancer drugs block dementia-linked brain inflammation, UCI study finds

A class of drugs developed to treat immune-related conditions and cancer – including one currently in clinical trials for glioblastoma and other tumors – eliminates neural inflammation associated with dementia-linked diseases and brain injuries, according to UC Irvine researchers.

In their study, assistant professor of neurobiology & behavior Kim Green and colleagues discovered that… Cancer drugs block dementia-linked brain inflammation, UCI study finds   



Design of micro and nanoparticles to improve treatments for Alzheimers and Parkinsons

Enara Herran, a researcher at the UPV/EHU’s Department of Pharmacy and Pharmaceutical Technology, is working to improve the way Alzheimer’s and Parkinson’s treatments are administered. And it is a fact that, as Herran herself stressed, “both diseases are becoming more and more common in our society”.

Both disorders affect the neurones: their structure and… Design of micro and nanoparticles to improve treatments for Alzheimers and Parkinsons   



Living With Dementia

hiv1 - amyloid markers1 - language impairment1 - sleep tied to alzheimer's1 - significant memory loss1 - familial alzheimer's disease2 - atypical antipsychotic drugs1 - symptoms of vascular dementia1 - prevent dementia4 - spread of alzheimers1 - agnosia3 - niaiserie1 - cognitive functioning2 - biomarkers in cerebrospinal fluid1 - psychosis polyneurotica1 - historical hypotheses1 - declines in memory1 - symptoms of dementia3 - encephalopathy-alcoholic10 - mild traumatic brain injury1 - dotage1 - autosomal dominant gene mutation1 - people with dementia4 - olive oil1 - dementia progression1 - stupidity or foolishness1 - tau tangles1 - csf1 - korsakoff amnesic syndrome1 - alzheimer's plaques1 -